Table 2. Number of newborns with TEP and BPR, per year and geographical region, in the period of 2000–2008 by Poisson distribution.
Brazil | Northeast | Southeast | South | |||||||||||||
Year | TEP | Births | BPR | CI 95% | TEP | Births | BPR | CI 95% | TEP | Births | BPR | CI 95% | TEP | Births | BPR | CI 95% |
2000 | 11 | 40104 | 2.74 | 1.40–4.90 | - | - | - | - | 6 | 12047 | 5.00 | 1.80–10.80 | 5 | 28057 | 1.80 | 0.60–4.20 |
2001 | 10 | 38742 | 2.50 | 1.20–4.70 | 0 | 5088 | 0.00 | 0.00–10.2 | 8 | 11876 | 6.74 | 2.90–13.30 | 2 | 21778 | 0.92 | 0.10–3.30 |
2002 | 10 | 40231 | 2.49 | 1.20–4.60 | 0 | 6617 | 0.00 | 0.00–7.8 | 8 | 12197 | 6.56 | 280–12.80 | 2 | 21417 | 0.93 | 0.10–3.40 |
2003 | 10 | 42061 | 2.38 | 1.10–4.40 | 0 | 10171 | 0.00 | 0.00–4.90 | 4 | 11466 | 3.50 | 0.90–8.90 | 6 | 20424 | 2.94 | 1.10–6.40 |
2004 | 11 | 42581 | 2.58 | 1.30–4.60 | 2 | 9733 | 2.10 | 0.20–7.40 | 5 | 11316 | 4.42 | 1.40–10.30 | 3 | 21532 | 1.40 | 0.30–4.10 |
2005 | 16 | 37518 | 4.26 | 2.40–6.90 | 7 | 10196 | 6.90 | 2.80–14.10 | 5 | 10909 | 4.60 | 1.50–10.70 | 5 | 16413 | 3.05 | 1.00–7.10 |
2006 | 15 | 38298 | 3.92 | 2.20–6.50 | 6 | 9341 | 6.42 | 2.30–14.00 | 4 | 13021 | 3.10 | 0.80–7.90 | 5 | 15936 | 3.24 | 1.00–7.30 |
2007 | 16 | 38281 | 4.18 | 2.40–6.80 | 2 | 8627 | 2.32 | 0.30–8.40 | 13 | 14658 | 8.90 | 4.70–13.20 | 1 | 14996 | 0.70 | 0.10–3.70 |
2008 | 10 | 34221 | 2.92 | 1.40–5.40 | 5 | 8920 | 5.60 | 1.80–13.10 | 3 | 13192 | 2.30 | 0.50–6.60 | 2 | 12109 | 1.65 | 0.20–6.00 |
Total | 109 | 352037 | 3.10 | 2.50–3.70 | 22 | 68693 | 3.20 | 2.00–4.80 | 56 | 110682 | 5.10 * | 3.80–6.80 | 31 | 172662 | 1.80 * | 1.20–2.50 |
Footnote: TEP: thalidomide embryopathy phenotype; BPR: birth prevalence rate; CI 95%: confidence interval of 95%.
*p<0.05.
-: year without monitoring by ECLAMC. BPR per 10 thousand births.